Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemophilia, Classic”

826 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 826 results

Post-approval studies (Phase 4)Study completedNCT02170402
What this trial is testing

China ADVATE PTP Study

Who this might be right for
Hemophilia A
Baxalta now part of Shire 82
Testing effectiveness (Phase 2)UnknownNCT03700229
What this trial is testing

Study to Evaluate Rituximab and Bortezomib in Patients With Newly Diagnosed Acquired Hemophilia A

Who this might be right for
Acquired Hemophilia A
Peking Union Medical College Hospital 22
Not applicableStudy completedNCT00853086
What this trial is testing

Post-marketing Safety Surveillance of NovoSeven® in Patients With Haemophilia and Inhibitors by Means of the UK Haemophilia Database

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B
Novo Nordisk A/S 139
Not applicableLooking for participantsNCT06702579
What this trial is testing

Home Monitoring in Hemophilia a

Who this might be right for
Hemophilia aAnticoagulant TherapyMonitoring+2 more
Radboud University Medical Center 30
Large-scale testing (Phase 3)Study completedNCT00037544
What this trial is testing

Study Evaluating ReFacto AF in Severe Hemophilia A

Who this might be right for
Hemophilia A
Wyeth is now a wholly owned subsidiary of Pfizer
Not applicableStudy completedNCT02460458
What this trial is testing

Type 3 Von Willebrand International Registries Inhibitor Prospective Study

Who this might be right for
Type 3 Von Willebrand's Disease
Fondazione Angelo Bianchi Bonomi 265
Large-scale testing (Phase 3)Looking for participantsNCT07416526
What this trial is testing

A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A

Who this might be right for
Hemophilia A
Hoffmann-La Roche 126
Not applicableStudy completedNCT00932555
What this trial is testing

EffeKt Taiwan- Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Taiwan

Who this might be right for
Hemophilia A
Bayer 82
Not applicableLooking for participantsNCT03549858
What this trial is testing

Patient Reported Outcomes Burdens and Experiences - Phase 3

Who this might be right for
HemophiliaChronic Disease
McMaster University 1,000
Not applicableLooking for participantsNCT04384341
What this trial is testing

Haemophilia and Bone Loss - PHILEOS Study

Who this might be right for
Hemophilia
Centre Hospitalier Universitaire de Saint Etienne 480
Not applicableStudy completedNCT02634723
What this trial is testing

Retrospective Chart Review to Evaluate Safety and Tolerability of ADVATE Among Previously Untreated Patients in China With Moderate to Severe Hemophilia A

Who this might be right for
Hemophilia A
Baxalta now part of Shire 21
Large-scale testing (Phase 3)Study completedNCT03191799
What this trial is testing

Evaluate the Safety and Tolerability of Prophylactic Emicizumab in Hemophilia A Patients With Inhibitors

Who this might be right for
Hemophilia A
Hoffmann-La Roche 195
Not applicableStudy completedNCT04076306
What this trial is testing

What is the Feasibility of the ISTEP Exercise Test in Boys With Haemophilia

Who this might be right for
Hemophilia
Great Ormond Street Hospital for Children NHS Foundation Trust 43
Large-scale testing (Phase 3)Study completedNCT01580293
What this trial is testing

A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A

Who this might be right for
Hemophilia A
Bayer 145
Not applicableUnknownNCT02554526
What this trial is testing

Basic Study of Combination Therapy Based on APCC-induced FVllI Activation in Hemophilia A Patients With Inhibitors

Who this might be right for
Hemophilia A With Inhibitor
Nara Medical University 10
Early research (Phase 1)Study completedNCT04015492
What this trial is testing

Study to Compare How the Body Distributes and Excretes the Drugs Jivi (BAY 94-9027) and Adynovi in Patients With Severe Hemophilia A (Bleeding Disorder Resulting From a Lack of Blood Clotting Factor VIII)

Who this might be right for
Hemophilia A
Bayer 18
Post-approval studies (Phase 4)Study completedNCT00571584
What this trial is testing

High Dose of Activated Recombinant Human Factor VII for Treatment of Mild/Moderate Joint Bleeds in Haemophilia Patients With Inhibitors

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 24
Not applicableNot Yet RecruitingNCT07420348
What this trial is testing

Incidence of Ultrasonographically Detected Articular Damage in Initially Healthy Joints of Patients With Hemophilia A Receiving Prophylactic Treatment With Emicizumab

Who this might be right for
Hemophilia
Investigación en Hemofilia y Fisioterapia 70
Not applicableStudy completedNCT05217992
What this trial is testing

Are There Differences Between Carriers of Haemophilia A and B?

Who this might be right for
Hemophilia
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 900
Large-scale testing (Phase 3)WithdrawnNCT02048111
What this trial is testing

Study of Recombinant Factor IX Product, IB1001, in Previously Treated Subjects With Hemophilia B

Who this might be right for
Hemophilia B
Cangene Corporation
Load More Results